BAYQ3939, 1000 mg Tablet in Transrectal Needle Biopsies of the Prostate (TRNBP) - Infection Prophylaxis

PHASE3CompletedINTERVENTIONAL
Enrollment

497

Participants

Timeline

Start Date

April 30, 2004

Study Completion Date

October 31, 2004

Conditions
Bacterial Infections
Interventions
DRUG

Ciprofloxacin single dose

Patients randomized to this regimen will receive a single-dose of ciprofloxacin MR 1000 mg PO approximately 2 to 3 hours prior to the TRNBP. Patients will also receive two doses of matching placebo approximately 24 hours prior to and approximately 24 hours after the TRNBP.

DRUG

Ciprofloxacin triple dose

Patients randomized to this regimen will receive three doses of ciprofloxacin MR 1000 mg PO. The doses will be approximately 24 hours prior to the TRNBP, approximately 2 to 3 hours prior to the TRNBP, and approximately 24 hours after the TRNBP.

Trial Locations (51)

19107

Philadelphia

20132

Milan

23510

Norfolk

24128

Bergamo

28034

Madrid

29681

Simpsonville

30076

Roswell

30342

Atlanta

34474

Ocala

35128

Padua

35209

Birmingham

36214

Vigo

41014

Seville

45170

Zapopan

46009

Valencia

60611

Chicago

64320

Monterrey

78229

San Antonio

80131

Napoli

86158

Villahermosa

91403

Sherman Oaks

92101

San Diego

94117

San Francisco

99202

Spokane

06708

Waterbury

01747

Hopedale

08901

New Brunswick

45212-2787

Cincinnati

43214-1419

Columbus

41920 000

Salvador

Unknown

Belo Horizonte

Rio de Janeiro

90470 340

Porto Alegre

04039-004

São Paulo

T2V 4R6

Calgary

T6G 2C8

Edmonton

V8R 6T9

Victoria

L8N 1T8

Hamilton

K7L 2V7

Kingston

N6A 4V2

London

M4H 1C3

Toronto

M4N 3M5

Toronto

G7H 1H2

Chicoutimi

J1H 5N4

Fleurimont

H7G 2E6

Laval

G1S 2L6

Québec

00155

Roma

06720

México D.F.

06700

México, D. F.

07760

México, D.F.

08035

Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY